Figures and Tables
From the following article:
Ted T. Ashburn & Meera S. Gupta
Nature Reviews Drug Discovery 5, 99-100 (February 2006)
doi:10.1038/nrd1961
Figure 1
IBS is a large and under-penetrated market.
Figure 2
Irritable bowel syndrome epidemiology.
Figure 3
The growth potential of the irritable bowel syndrome market.
Table 1
Irritable bowel syndrome drugs on the market and in clinical development
